ANGELA ATHAR: Open Payments
NPI 1033248265 · ORANGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 25 payments from 9 companies in 2025. Trend: 2023 $347 · 2024 $915 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $96 |
| Novo Nordisk Inc | 5 | $93 |
| SANOFI-AVENTIS U.S. LLC | 1 | $91 |
| PFIZER INC. | 5 | $88 |
| IBSA Pharma Inc. | 3 | $62 |
| Amgen Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ABBVIE INC. | 1 | $22 |
Products named: MOUNJARO, TZIELD, Tirosint, Ozempic, PREVNAR 20, OTEZLA, Ohtuvayre, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
